摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[N-(6-(2,4-dioxo-1,3-thiazolidin-3-yl)hexyl)]-1-azonia-3,5,7-triazatricyclodecane bromide | 1333000-95-5

中文名称
——
中文别名
——
英文名称
1-[N-(6-(2,4-dioxo-1,3-thiazolidin-3-yl)hexyl)]-1-azonia-3,5,7-triazatricyclodecane bromide
英文别名
——
1-[N-(6-(2,4-dioxo-1,3-thiazolidin-3-yl)hexyl)]-1-azonia-3,5,7-triazatricyclodecane bromide化学式
CAS
1333000-95-5
化学式
Br*C15H26N5O2S
mdl
——
分子量
420.374
InChiKey
HTXJBLSUKMUHGK-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.25
  • 重原子数:
    24.0
  • 可旋转键数:
    7.0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.87
  • 拓扑面积:
    47.1
  • 氢给体数:
    0.0
  • 氢受体数:
    6.0

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Design, synthesis, and biological evaluation of novel 2,4-thiazolidinedione derivatives as histone deacetylase inhibitors targeting liver cancer cell line
    摘要:
    As a part of an ongoing effort to find alternate chemotherapeutic agents for hepatocellular carcinoma, we herein, report the design and synthesis of two novel compounds targeting histone deacetylase (HDAC) with 2,4-thiazolidinedione as zinc chelating group. Further, we demonstrate that these compounds show cytotoxicity that parallels their ability to inhibit HDACs activity in human liver cancer cell line HepG2. The findings obtained in this study indicate that 2,4-thiazolidinedione group may be utilized successfully to inhibit HDAC activity with future potential for lead optimization by chemical derivatization of active compound, N-(6-(2,4-dioxothiazolidin-3- yl)hexyl) benzenesulfonamide.
    DOI:
    10.1007/s00044-011-9623-3
  • 作为产物:
    参考文献:
    名称:
    Design, synthesis, and biological evaluation of novel 2,4-thiazolidinedione derivatives as histone deacetylase inhibitors targeting liver cancer cell line
    摘要:
    As a part of an ongoing effort to find alternate chemotherapeutic agents for hepatocellular carcinoma, we herein, report the design and synthesis of two novel compounds targeting histone deacetylase (HDAC) with 2,4-thiazolidinedione as zinc chelating group. Further, we demonstrate that these compounds show cytotoxicity that parallels their ability to inhibit HDACs activity in human liver cancer cell line HepG2. The findings obtained in this study indicate that 2,4-thiazolidinedione group may be utilized successfully to inhibit HDAC activity with future potential for lead optimization by chemical derivatization of active compound, N-(6-(2,4-dioxothiazolidin-3- yl)hexyl) benzenesulfonamide.
    DOI:
    10.1007/s00044-011-9623-3
点击查看最新优质反应信息

文献信息

  • Fast RNA conjugations on solid phase by strain-promoted cycloadditions
    作者:Ishwar Singh、Colin Freeman、Annemieke Madder、Joseph S. Vyle、Frances Heaney
    DOI:10.1039/c2ob25628b
    日期:——
    Strain promoted cycloaddition is presented as a tool for RNA conjugation on the solid phase; RNA-cyclooctyne conjugates are prepared by cycloaddition to both azide (strain-promoted azide–alkyne cycloaddition, SPAAC) and nitrile oxide dipoles (strain-promoted nitrile oxide–alkyne cycloaddition, SPNOAC). The conjugation is compatible with 2′-OMe blocks and with 2′-O-TBDMS protection on the ribose moieties
    菌株促进的环加成反应被认为是固相上RNA结合的工具。RNA-环辛炔共轭物是通过环加成叠氮化物(应变促进的叠氮化物-炔烃环加成,SPAAC)和一氧化二氮偶极(应变促进的腈氧化物-炔烃环加成,SPNOAC)而制备的。该缀合物与糖的核糖部分上的2'-OMe嵌段和2'- O- TBDMS保护相容。发现一氧化二氮偶极子比叠氮化物更具反应性。在室温下,在性溶剂中,在没有任何属催化剂的情况下,共轭反应会在10分钟内进行,并能耐受具有不同空间体积和电子要求(包括pyr基)的偶极子,香豆素十二烷基衍生物
查看更多

同类化合物

(4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] 香豆素-6-羧酸 顺式-3a,5,6,6a-四氢-3-(1-甲基乙基)-4H-环戊二烯并[d]异恶唑 锌离子载体IV 钐(III) 离子载体 II 苯,1-(2E)-2-丁烯-1-基-2-氟- 苯,(2,2-二氟乙烯基)- 聚二硫二噻唑烷 缩胆囊肽9 绕丹酸钠 盐(1:?)5'-尿苷酸,钠 甲酰乙内脲 甲巯咪唑 甲基羟甲基油基噁唑啉 甲基5-羟基-3,5-二甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-甲基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基5-甲基-4,5-二氢-1H-吡唑-1-羧酸酯 甲基5-氰基-4,5-二氢-1,2-恶唑-3-羧酸酯 甲基5-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基5-(羟基甲基)-4,5-二氢-1,2-恶唑-3-羧酸酯 甲基4-甲基-5-氧代-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-甲基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4-乙炔基-4,5-二氢-1H-吡唑-3-羧酸酯 甲基4,5-二氮杂螺[2.4]庚-5-烯-6-羧酸酯 甲基4,5-二氢-5-乙基-1H-吡唑-1-羧酸酯 甲基3-甲基-4,5-二氢-1,2-恶唑-4-羧酸酯 甲基(E)-3-[6-[1-羟基-1-(4-甲基苯基)-3-(1-吡咯烷基)丙基]-2-吡啶基]丙烯酰酸酯 甲基(5-氧代-4,5-二氢-1,2-恶唑-3-基)乙酸酯 环戊二烯并[d]咪唑-2,5(1H,3H)-二硫酮 环己羧酸,3-氨基-2-甲氧基-,甲基酯,(1S,2S,3S)- 溶剂黄93 溴化1-十六烷基-3-甲基咪唑 溴化1-十二烷基-2,3-二甲基咪唑 泰比培南酯中间体 泰比培南酯中间体 氨甲酸,[4,5-二氢-4-(碘甲基)-2-噻唑基]-,1,1-二甲基乙基酯(9CI) 氨基甲硫酸,[2-[[(2-羰基-1-咪唑烷基)硫代甲基]氨基]乙基]-,O-甲基酯 异噻唑,4,5-二氯-2,5-二氢-2-辛基- 希诺米啉 四氟硼酸二氢1,3-二(叔-丁基)-4,5--1H-咪唑正离子 四唑硝基紫 噻唑烷-2,4-二酮-2-缩氨基脲 噻唑丁炎酮 噻唑,4,5-二氢-4-(1-甲基乙基)-,(S)- 噁唑,4,5-二氢-4,4-二甲基-2-(5-甲基-2-呋喃基)- 噁唑,2-庚基-4,5-二氢- 咪唑烷基脲 吡嗪,2,3-二氢-5,6-二甲基-2-丙基- 叔-丁基3-羟基-1,4,6,7-四氢吡唑并[4,3-c]吡啶-5-羧酸酯 双吡唑啉酮